Navigation Links
Advanced Life Sciences Announces Second Quarter 2008 Financial Results
Date:8/14/2008

nical development and manufacturing costs associated

with the Company's lead product, cethromycin.

* Selling, general and administrative expenses totaled $1.7 million

compared to $1.8 million for the second quarter of last year.

Recent Achievements

* Incorporated knowledge gained in April meetings with FDA to optimize

cethromycin NDA for the community acquired pneumonia (CAP)

indication;

* Progressed negotiations with prospective partners for the

commercialization of cethromycin;

* Announced U.S. Department of Defense DTRA contract to study

cethromycin in tularemia, plague and melioidosis for up to

$3.8 million;

* Submitted funding proposal to Department of Health & Human Services

to expand the application of cethromycin as a broad spectrum medical

countermeasure. If awarded, the contract would further support

advanced development for cethromycin to combat Category A and B

bioterror threats such as inhalation anthrax, tularemia, plague and

melioidosis;

* Published data in Journal of Antimicrobial Chemotherapy showing

potent cethromycin in vitro CA-MRSA activity;

* Opened enrollment and began screening patients in dose-escalating

study to assess the safety, tolerability, and preliminary efficacy

of ALS-357 topically administered to patients with cutaneous

metastatic melanoma;

* Announced collaboration with UK Ministry of Defence for study of

ALS-886 as a treatment for lung tissue damage.

Business Outlook and Goals for the Third Quarter of 2008

* Submit electronic NDA package for cethromycin in the CAP indication

to the FDA;

* Advance negotiations with prospective partners for the

commercialization of cethromycin;

*
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... In chemical and petrochemical plants, and ... The rapid rise of TDL analyzers over recent ... a core gas measurement technology, and their high ... gas analyzer technology of choice for many companies. ... processes have limited their application range. METTLER TOLEDO's ...
(Date:7/22/2014)... July 22, 2014  Semler Scientific, Inc. (Nasdaq: ... risk assessment company that develops patented products that ... chronic diseases, today announced that it will report ... of U.S. financial markets on July 25, 2014. Doug Murphy-Chutorian, ... a conference call at 11 a.m. EDT, July 25, 2014. ...
(Date:7/22/2014)... CAMBRIDGE, Mass. , July 22, 2014 /PRNewswire/ ... of $650 million from philanthropist Ted Stanley ... disorders and bringing new treatments based on molecular ... the world. The Stanley commitment ... among the largest for scientific research in general ...
(Date:7/22/2014)... Quorum Review IRB, the industry leader in central IRB services, ... Quick Step™ . The offering went live on July 1, ... for seamless study start-up with a large volume of researcher ... or more North American investigator sites, as well as related ... 80 or more. Qualifying studies may also enroll international sites ...
Breaking Biology Technology:METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3
... the managing director of the Wisconsin Alumni Research Foundation ... Public Advisory Committee, officials have announced. He will help guide ... procedures. , , Gulbrandsen Gulbrandsen first found out ... Secretary of Commerce Donald Evans. Now a part-time federal government ...
... Milwaukee Merge Technologies Incorporated has closed ... $6 million in cash. Both companies make medical imaging software. ... renewed through 2010 its deal to buy managed network and ... headquartered near Toronto, Canada. Johnson Controls officials said outsourcing nearly ...
... Monday announcement that it plans to buy its former ... eyes open for new opportunities. , ,Drew Petersen, director of ... between SBC and AT&T is a sign that SBC plans ... regional one. TDS, which Petersen said tries to present itself ...
Cached Biology Technology:WARF director to advise U.S. patent office 2SBC merger with AT&T could open opportunities in Wisconsin 2
(Date:7/22/2014)... 22, 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric ... announces its next generation smart wallet, Wocket™, will be featured ... show that airs on the History Channel, FYI ... regularly features top technology products and services. The ... History Channel (6:00-6:30am ET/PT) and the FYI Network ...
(Date:7/22/2014)... Cleveland: A type of immune cell widely believed ... Alzheimer,s disease and multiple sclerosis (MS), can actually ... and may slow the progression of neurodegenerative diseases, ... the online journal Nature Communications . , ... Chair of the Department of Neurosciences at Cleveland ...
(Date:7/22/2014)... the genus of planthopper known as Conosimus, which now ... discovered in the southern part of the Iberian Peninsula ... it appears in the open-access Journal of Insect ... species, Conosimus baenai , has been named after ... the taxonomy of Iberian Hemiptera. , Conosimus baenai ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... units, called plasmids, found in one of the ... microorganism Agrobacterium tumefaciens -- Indiana University ... these plasmids benefit while the virulent, disease-causing plasmids ... hosts. The research confirms that the ability of ...
... Ariz. Feb. 1, 2012 The U.S. National ... precedent-setting policy statement warning about the "unusually high magnitude" ... The NSABB is chaired by Dr. Paul Keim, Director ... Research Institute (TGen), and a Regents Professor of Biology ...
... in German . , The DFG,s Senate ... in the Work Area has evaluated the state of research ... and safety since 1955. The publication of the MAK Collection ... access to electronic information resources. The database, which contains detailed ...
Cached Biology News:Bacterial plasmids -- the freeloading and the heavy-lifters -- balance the high price of disease 2TGen-NAU professor leads national panel in precedent-setting policy published in Science and Nature 2Open access: Comprehensive occupational health and safety resource now available online 2
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
... Applied Biosystems and MDS Sciex ... System, a high performance hybrid triple ... the drug discovery, drug development or ... (LIT) Technology from the leaders in ...
... EpiTect Bisulfite Kit enables complete conversion ... less than 6 hours. The highly ... against DNA degradation and a spin-column-based ... fast and reliable results for all ...
... Shimadzus GCMS-QP2010s Gas Chromatograph/Mass Spectrometer, ... of the GCMS-QP2010 Plus, offers high ... with an excellent performance-to-cost ratio. Like ... patented constant linear velocity for optimum ...
Biology Products: